DOI: http://dx.doi.org/10.18203/2349-2902.isj20184646

Clinical presentation and management of locally advanced breast carcinoma

Manik C. Gedam, Keval Shukla, Leena Y. Ingale

Abstract


Background: Locally advanced breast cancer (LABC) encompasses a heterogeneous collection of breast neoplasia with widely different clinical and biological characteristics. Multidisciplinary therapy has become the treatment of choice for these patients. The present study was undertaken to study the clinical presentation and effects of various modes of management of LABC.

Methods: Total 45 patients presented with stage III and inflammatory carcinoma of breast were included in the study and treated with neoadjuvant chemotherapy, followed by surgery and radiotherapy. Clinical and pathological responses to different chemotherapy regimens were assessed according to World Health Organization criteria. Results: Majority of patients were in stage IIIA (55.6%) followed by stage IIIB (37.7%). Lump was most common symptom in all the cases followed by distortion of nipple (35.5%). After neoadjuvant chemotherapy, 70% of cases had clinical partial response and 25% of cases had clinical complete response and all except one case were converted from inoperable to operable cases. Histopathology was found to be infiltrating ductal carcinoma in 91.1% of cases. Flap necrosis (27.2%) and seroma (15.9%) was major complications of surgery while alopecia (88.8%), anemia (62.2%) were major complications of chemotherapy. Follow up data suggested that 77.7% patients doing well. One patient had expired after developing distant metastasis and 20% patients were lost to follow up.

Conclusions: Treatment of LABC is multimodal and neoadjuvant chemotherapy converts inoperable cases to operable cases and improves longevity of life of the patient. The results of inflammatory carcinoma remain to be dismal in spite of multimodality treatment.


Keywords


Adjuvant therapy, Histopathology, Inflammatory carcinoma, Locally advanced breast carcinoma, Neoadjuvant chemotherapy

Full Text:

PDF

References


Valero VV, Buzdar AU, Hortobagyi GN. Locally advanced breast cancer. Oncologist. 1996;1:8-17.

Bhattacharyya T, Sharma SC, Yadav BS, Singh R, Singh G. Outcome of neoadjuvant chemotherapy in locally advanced breast cancer: a tertiary care centre experience. Indian J Med Paediatr Oncol. 2014;35:215-20.

Taghian A, ElGhamry MN, Merajver SD. Clinical features and management of locally advanced breast cancer. UpToDate. 2018;1-10. Available at http://www.uptodate.com/online

Haagensen CD, Stout AP. Carcinoma of the breast: II. Criteria of operability. Ann Surg. 1943;118:859.

Atkins HL, Horrigan WD. Treatment of locally advanced carcinoma of the breast with roentgen therapy and simple mastectomy. Am J Roentgenol Radium Ther Nucl Med. 1961;85:860.

Fletcher GH. Local results of irradiation in the primary management of localized breast cancer. Cancer. 1972;29:545.

Toonkel LM, Fix I, Jacobson LH, et al. Locally advanced breast carcinoma: results with combined regional therapy. Int J Radiat Oncol Biol Phys. 1986;12:1583.

Chopra R. The Indian scene. J Clin Oncol. 2001;19:S106-11.

Goel A, Bhan CM, Srivastava KN. Five-year clinico pathological study of breast cancer. Indian J Med Sci. 2003;57:347.

Sen AK, Gupta DTK. Cancer of the breast and its treatment. Ind J Surg. 1962:833-47.

Viswambharan JL, Kadambari D, Iyengar KR, Srinivasan K. Feasibility of breast conservation surgery in locally advanced breast cancer downstaged by neoadjuvant chemotherapy: a study in mastectomy specimens using simulationlumpectomy. Indian J Cancer. 2005;42:30-4.

Yadav BS, Sharma SC, Singh R, Singh G. Patterns of relapse in locally advanced breast cancer treated with neoadjuvant chemotherapy followed by surgery andradiotherapy. J Can Res Ther. 2007;3:75-80.

Kuraparthy S, Reddy KM, Yadagiri LA, Yutla M, Venkata PB, Kadainti SV, et al. Epidemiology and patterns of care for invasive breast carcinoma at a community hospital in Southern India. World J Surg Oncol. 2007;5(1):56.

Sandhu DS, Sandhu S, Karwasra RK, Marwah S. Profile of breast cancer patients at a tertiary care hospital in north India. Indian J Cancer. 2010;47:16-22.

William G. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma. Ann Surg. 2002;236(3):295-303.

Nolen BM, Marks JR, Ta'san S, Rand A, Wang Y, Blackwell K, et al. Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer. Breast Cancer Res. 2008;10(3):R45.

Conte PF, Alama A, Bertelli G. Chemotherapy with oestrogenic recruitment and surgery in LABC, Clinical and cytokinetic results. Int J Cancer. 1987;40:49.

Raina V, Bhutani M, Bedi R. Clinical features and prognostic factors of early breast cancer at a major cancer in North India. Ind J Cancer. 2005;42:40-5.

Rustogi A, Budrukkar A, Dinshaw K, Jalali R. Management of locally advancedbreast cancer: Evolution and current practice. J Can Res Ther. 2005;1:21-30.

Baldini E, Gardin G, Giannessi PG, Evangelista G, Roncella M, Prochilo T, et al. Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: A randomized phase III trial in locally advanced breast cancer. Ann Oncol. 2003;14:227-32.

Raut NV, Chordiya N. Neo adjuvant chemotherapy in breast cancer: What have we learned so far? Indian J Med Paediatr Oncol. 2010;31:8-17.

Sethi D, Sen R, Parshad S, Khetarpal S, Garg M, Sen J. Histopathologic changes following neoadjuvant chemotherapy in locally advanced breast cancer. Indian J Cancer. 2013;50:58-64.

Peled AW, Itakura K, Foster RD, Hamolsky D, Tanaka J, Ewing C, et al. Impact of chemotherapy on postoperative complications after mastectomy and immediate breast reconstruction. Arch Surg. 2010;145(9):880-5.

Rocco N, Rispoli C, Pagano G, Rengo G, Compagna R, Danzi M, et al. Breast cancer surgery in elderly patients: postoperative complications and survival. BMC Surg. 2013;13(2):S25.